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Summary
Background: The majority of oocytes in the mammalian ovary
are dormant oocytes that are enclosed in primordial follicles by
several somatic cells, which we refer to as primordial follicle
granulosa cells (pfGCs). Very little is known, however, about
how the pfGCs control the activation of primordial follicles
and the developmental fates of dormant oocytes.
Results: By targeting molecules in pfGCs with several mutant
mouse models, we demonstrate that the somatic pfGCs
initiate the activation of primordial follicles and govern the
quiescence or awakening of dormant oocytes. Inhibition of
mTORC1 signaling in pfGCs prevents the differentiation of
pfGCs into granulosa cells, and this arrests the dormant
oocytes in their quiescent states, leading to oocyte death.
Overactivation of mTORC1 signaling in pfGCs accelerates
the differentiation of pfGCs into granulosa cells and causes
premature activation of all dormant oocytes and primordial fol-
licles. We further show that pfGCs trigger the awakening of
dormant oocytes through KIT ligand (KITL), and we present
an essential communication network between the somatic
cells and germ cells that is based on signaling between the
mTORC1-KITL cascade in pfGCs and KIT-PI3K signaling in
oocytes.
Conclusions: Our findings provide a relatively complete pic-
ture of how mammalian primordial follicles are activated. The
microenvironment surrounding primordial follicles can acti-
vate mTORC1-KITL signaling in pfGCs, and these cells trigger
the awakening of dormant oocytes and complete the process
of follicular activation. Such communication between the
microenvironment, somatic cells, and germ cells is essential
to maintaining the proper reproductive lifespan in mammals.
Introduction
The development and differentiation of female germ cells
require a unique microenvironment created by surrounding
somatic cells. InCaenorhabditis elegans, both the self-renewal
of germline stem cells (GSCs) and the differentiation of GSCs
into meiosis-competent oocytes rely heavily on the involve-
ment of the somatic cell niche found at the distal tip of the
germline tissue [1, 2]. In Drosophila, the somatic cell niche in
the ovary supports the self-renewal of the GSCs and is*Correspondence: kui.liu@gu.seessential to maintaining germ cell production throughout adult
life [2, 3].
Inmammalian ovaries, themajority of oocytes exist as small,
dormant oocytes that are meiotically arrested and are en-
closed in primordial follicles by several flattened somatic cells
[4, 5], which we refer to here as primordial follicle granulosa
cells (pfGCs) (Figure 1A). In order to ensure the proper length
of the organism’s reproductive lifespan, most of the oocytes
are maintained in a quiescent state. In humans, for example,
dormant oocytes can remain in a developmentally quiescent
state for as long as 50 years. However, the functions of sur-
rounding somatic pfGCs in regulating follicular activation and
the developmental fates of dormant oocytes are unclear.
To generate mature eggs in the mammalian ovary, only a
limited number of dormant oocytes are progressively acti-
vated into the growing pool. During follicular activation, the
dormant oocytes are awakened into a phase of rapid growth
with hundreds-fold increases in volume along with massive
amounts of mRNA transcription and protein translation [6].
Pioneering studies have reported that the awakening process
in mammalian oocytes is associated with morphological
changes of the surrounding somatic pfGCs—the flattened
pfGCs first proliferate and differentiate into cuboidal granulosa
cells, and this is followed by the dramatic growth of the
oocytes [5, 7]. Conventional knockout of Forkhead box L2
(Foxl2), which is an important gene for the differentiation of
follicle somatic cells, leads to a mild global activation of the
follicular pool [8, 9]. These results indicate a functional role
of the pfGCs in regulating the fates of dormant oocytes in
the mammalian ovary. However, due to limitations of research
tools—such as the lack of a suitable promoter that specifically
targets pfGCs in vivo—whether and how the somatic pfGCs
might regulate the activation of primordial follicles and
contribute to the awakening of dormant oocytes in the
mammalian ovary are unknown.
mTORC1 (mechanistic target of rapamycin complex 1) is a
conserved serine/threonine kinase that regulates cell growth
and metabolism in response to growth factors and nutrients.
It functions by modulating processes such as protein synthe-
sis, ribosome biogenesis, and autophagy [10]. mTORC1 is
composed of several components, including RPTOR, which
is the regulatory-associated protein of mTOR. In cells,
mTORC1 signaling is negatively regulated by the tumor sup-
pressor tuberous sclerosis complex 1 (TSC1) [11]. However,
the functional role of mTORC1 signaling in pfGCs is unclear.
In the current study, we have targeted the somatic pfGCs by
using a pfGC-specific, tamoxifen-inducible Foxl2-CreERT2
mouse model [12]. Our results show that in mammals, pfGCs
initiate the activation of primordial follicles and govern the
quiescence or awakening of dormant oocytes. More specif-
ically, by combining several mutant mouse models, we have
shown that mTORC1 signaling in pfGCs plays a central role
in regulating the differentiation of pfGCs into granulosa cells
and in guiding the development of dormant oocytes through
mTORC1-mediated expression of KIT ligand (KITL) in pfGCs.
Binding of KITL to KIT on the surface of the oocytes activates
the phosphatidylinositol 3-kinase (PI3K) signaling cascade
in dormant oocytes and the subsequent awakening of the
Figure 1. Deletion of Rptor in PfGCs Suppresses Follicular Activation and the Awakening of Dormant Oocytes
(A) The awakening of a dormant oocyte during follicular activation. A primordial follicle consists of a dormant oocyte and several surrounding pfGCs. The
activation of primordial follicles startswith the differentiation of flattened pfGCs into cuboidal granulosa cells and the proliferation of the granulosa cells. This
is followed by robust growth of the awakened oocyte.
(B) Illustration of the deletion of exon 6 of Rptor in the pfGCs of pfGC-Rptor2/2 mice after neonatal tamoxifen injection.
(C) Western blot showing suppressed mTORC1 signaling in pfGC-Rptor2/2mouse ovaries. Levels of total RPS6KB1, EIF4EBP1, and b-actin were used as
internal controls. For each lane, 20 mg protein lysate from PD13 pfGC-Rptor2/2 or pfGC-Rptor+/+ mouse ovaries was loaded.
(D and E) Comparable ovarian morphology in pfGC-Rptor+/+ (D) and pfGC-Rptor2/2 (E) mice at PD5 after tamoxifen administration at PD1 and PD4
(20 mg$kg21 body weight).
(F–I) At PD13, the pfGC-Rptor2/2 ovaries (G and I) are smaller than the pfGC-Rptor+/+ ovaries (F and H). Numerous primordial follicles (G and I, arrow-
heads) but only a few growing follicles (G, arrows) were observed in the pfGC-Rptor2/2 ovary. The experiments were repeated at least three times, and
representative images are shown.
See also Figure S1.
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and germ cells in the mouse ovary serves as the initial molec-
ular event that triggers the progressive activation of dormant
oocytes into fertilizable eggs.
Results
Deletion of Rptor Specifically in PfGCs Suppresses
mTORC1 Signaling in PfGCs
To determine how the somatic pfGCs might regulate follicular
activation and the quiescence and awakening of dormant
oocytes, we deleted Rptor (regulatory-associated protein of
MTOR, complex 1)—the key component of the mTORC1
pathway—in pfGCs by crossing RptorloxP/loxP mice with a
knockin mouse line expressing tamoxifen-inducible Foxl2 pro-
moter-mediated CreERT2 fusion protein (Foxl2-CreERT2 mice)
(Figure 1B) [12]. The resulting mice are referred to as pfGC-
Rptor2/2 mice (indicating pfGC-specific knockout of Rptor)
and were validated as described below.
We first crossed the Foxl2-CreERT2 mice with an mTmG re-
porter mouse line in which Cre recombinase-targeted cells
exhibit a switch from red fluorescence (membrane-targeted
Tomato; mT) to green fluorescence (membrane-targeted
GFP; mG) [13]. In mice, the Foxl2 promoter becomes activeduring the perinatal period, when the ovarian supporting cells
differentiate into pfGCs and start to form primordial follicles,
and Foxl2 is expressed in both pfGCs and granulosa cells
[14]. We showed that tamoxifen administration to postnatal
day (PD)1 and PD4 Foxl2-CreERT2;mTmG pups (20 mg$kg21
body weight) can successfully target pfGCs with high effi-
ciency and specificity (Figure S1A available online, pfGCs
with green fluorescence) [12]. As a negative control, no green
fluorescent cells were seen in mTmG mice injected with
tamoxifen (Figure S1B). Western blot analysis showed a satis-
factory reduction of RPTOR expression in the ovarian lysates
of PD13 pfGC-Rptor2/2 mice (Figure 1C, RPTOR), and this
led to impaired mTORC1 signaling as shown by reduced
phosphorylation of RPS6KB1 and EIF4EBP1 (Figure 1C,
p-RPS6KB1 T389 and p-EIF4EBP1 S65).
Deletion of Rptor in PfGCs Prevents the Awakening of
Dormant Oocytes and Suppresses Follicular Activation
To delete Rptor from pfGCs, tamoxifen was administered at
PD1 and PD4. At PD5, the ovaries from pfGC-Rptor2/2 mice
and pfGC-Rptor+/+ control mice had similar morphologies,
with mostly primordial follicles (Figures 1D and 1E, arrow-
heads) and some follicles that were likely to have been acti-
vated before the tamoxifen-induced Cre recombinase became
Figure 2. Deletion of Tsc1 in PfGCs Leads to thePremature Awakening of All
Dormant Oocytes and the Activation of All Primordial Follicles
Tamoxifen was administered to pups at PD1 and PD4 (20 mg$kg–1 body
weight).
(A) Illustration of the deletion of exons 17 and 18 of Tsc1 in the pfGCs of
pfGC-Tsc12/2 mice.
(B) Western blot showing enhanced mTORC1 signaling in pfGC-Tsc12/2
mouse ovaries. Levels of total RPS6KB1 and b-actin were used as
internal controls. For each lane, 20 mg protein lysate from 13-day-old
pfGC-Tsc12/2 or pfGC-Tsc1+/+ mouse ovaries was loaded.
(C and D) The ovarianmorphologies are comparable in pfGC-Tsc1+/+ (C) and
pfGC-Tsc12/2 (D) mice at PD10.
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2503active (Figures 1D and 1E, arrows) [12]. This indicated that the
postnatal deletion of Rptor in Foxl2-positive cells does not
affect the formation of primordial follicles.
At PD13, however, the pfGC-Rptor2/2 ovaries were much
smaller (Figure 1G) compared to the pfGC-Rptor+/+ ovaries,
in which numerous activated follicles were seen (Figures 1F
and 1H, arrows). Most of the oocytes in the mutant ovaries re-
mained in a quiescent state in primordial follicles (Figures 1G
and 1I, arrowheads). Only a few follicles were activated in the
pfGC-Rptor–/– ovaries (Figure 1G, arrows), and this most likely
occurred before the complete deletion of Rptor in pfGCs. At
sexual maturity (PD35), in comparison to the normal follicular
development in pfGC-Rptor+/+ ovaries (Figure S1C, arrow),
the pfGC-Rptor2/2 ovaries remained smaller (Figure S1D,
inset) because they still contained large numbers of dormant
oocytes in primordial follicles (Figure S1D, arrowheads). Quan-
tification of follicles in pfGC-Rptor+/+ and pfGC-Rptor2/2
ovaries at PD5, PD13, and PD35 confirmed the suppressed
follicular activation in pfGC-Rptor2/2 ovaries (Figure S1G).
These dormant oocytes that are arrested in the quiescent state
inmutant ovaries eventually die out at around 4months of age,
and no healthy oocytes or follicles were observed in the
pfGC-Rptor2/2 ovaries (Figure S1F). This is in sharp contrast
to the normal follicular development in pfGC-Rptor+/+ ovaries
(Figure S1E, arrows). It is thus not surprising that the pfGC-
Rptor2/2 females were infertile.
Our results show that the deletion of Rptor in pfGCs sup-
presses follicular activation and prevents the awakening of
dormant oocytes.
Deletion of Tsc1 in PfGCs Leads to the Global Awakening
of Dormant Oocytes and the Activation of All Primordial
Follicles
TSC1 is an inhibitor of mTORC1 signaling [15]. To confirm that
the mTORC1 signaling in pfGCs controls the quiescence or
awakening of dormant oocytes, we specifically deleted the
Tsc1 gene from pfGCs by crossing the Tsc1loxP/loxP mice with
Foxl2-CreERT2 mice (Figure 2A). The resulting mice are
referred to as pfGC-Tsc12/2 mice. Western blot analysis
showed that the reduction of TSC1 expression (Figure 2B,
TSC1) resulted in enhanced activation of mTORC1 signaling
in pfGC-Tsc12/2 ovaries, as illustrated by the elevated level
of phosphorylated RPS6KB1 (Figure 2B, p-RPS6KB1 T389).
Tamoxifen was administered to pfGC-Tsc12/2 mice at PD1
and PD4. No apparent morphological difference in oocyte
development was observed at PD10 between pfGC-Tsc1+/+
(Figure 2C) and pfGC-Tsc12/2 (Figure 2D) ovaries. At PD23,
however, the pfGC-Tsc12/2 ovaries (Figure 2F) were much
larger than the pfGC-Tsc1+/+ ovaries (Figure 2E). This was
caused by the premature awakening of all dormant oocytes
and activation of all primordial follicles in pfGC-Tsc12/2
ovaries (Figures 2F and 2H, arrows). Notably, all flattened
pfGCs had differentiated into cuboidal granulosa cells in the(E–H) By PD23, few primordial follicles or dormant oocytes were observed in
pfGC-Tsc12/2 ovaries, and almost all of the primordial follicles developed
into primary or secondary follicles with enlarged oocytes (F and H, arrows)
and cuboidal granulosa cells (H, arrowheads). This is in sharp contrast to the
primordial follicles (G, arrowheads) in pfGC-Tsc1+/+ ovaries.
(I and J) At PD13, the expression of FOXO3 is located in the nuclei of oocytes
in primordial follicles in pfGC-Tsc1+/+mice (I). In contrast, FOXO3 has trans-
located to the cytoplasm in most oocytes of pfGC-Tsc12/2 ovaries (J), indi-
cating activated PI3K signaling in the oocytes. The experiments were
repeated at least three times, and representative images are shown.
See also Figure S2.
Figure 3. mTORC1 Signaling in PfGCs Triggers
the Awakening of Dormant Oocytes through the
Interaction between KITL and Oocyte KIT
(A–C) Morphological analysis of pfGC-Tsc12/2
ovaries after in vitro culture with vehicle, rapamy-
cin, or ISCK03. Tamoxifen was administered to
pups at PD1 and PD4 (20 mg$kg21 body weight),
and the ovaries were collected at PD10 and
cultured in vitro. After a 4-day in vitro culture,
premature awakening of oocytes in the pfGC-
Tsc12/2 ovaries was seen (A, arrows). Such
overactivation of dormant oocytes was sup-
pressed, and primordial follicles were observed
in pfGC-Tsc12/2 ovaries cultured with the
mTORC1 inhibitor rapamycin (B, arrowheads).
The awakening and enlargement of oocytes
were also suppressed in pfGC-Tsc12/2 ovaries
cultured with the KIT inhibitor ISCK03 (C, arrow-
heads), indicating that KIT signaling in oocytes
is involved in the awakening of dormant oocytes
and functions downstream of the mTORC1
pathway in pfGCs.
(D) Quantification of Kit ligand mRNA expression
in pfGC-Tsc12/2 and pfGC-Tsc1+/+ ovaries.
Tamoxifen was administered to females at PD1
and PD4. Ovaries were isolated from PD5 or
PD13 pfGC-Tsc12/2 and pfGC-Tsc1+/+ mice.
At PD5, comparable expression levels of Kitl
mRNA were detected in pfGC-Tsc12/2 and
pfGC-Tsc1+/+ ovaries. At PD13, the expression
of Kitl mRNA was increased in ovaries of both
genotypes, but the Kitl mRNA level in pfGC-
Tsc12/2 ovaries was 2.3 times that of the pfGC-
Tsc1+/+ ovaries. The mRNA levels in PD5 pfGC-Tsc1+/+ ovaries were defined as 1.0. The mRNA level of Gapdh was used as the internal control. For each
experiment, materials from eightmicewere used and data are represented asmeans6SEM. The experiments were repeated at least three times, and repre-
sentative images are shown.
See also Figure S3.
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2504pfGC-Tsc12/2 ovaries (Figure 2H, arrowheads). This is in sharp
contrast to the pfGC-Tsc1+/+ ovaries that contained many
dormant oocytes in primordial follicles (Figure 2G, arrow-
heads). As expected, at PD35, the pfGC-Tsc12/2 ovaries (Fig-
ure S2D) were still larger than the pfGC-Tsc1+/+ ovaries
(Figure S2C) due to higher numbers of developing follicles con-
taining growing oocytes and a lack of dormant oocytes in pri-
mordial follicles in the pfGC-Tsc12/2 ovaries (Figure S2D,
inset). In comparison, primordial follicles were observed in
pfGC-Tsc1+/+ ovaries (Figure S2C, inset, arrows). Quantifica-
tion of follicles in pfGC-Tsc1+/+ and pfGC-Tsc12/2 ovaries at
PD8, PD23, and PD35 confirmed the premature global follic-
ular activation in pfGC-Tsc12/2 ovaries (Figure S2G). The
prematurely activated follicles in pfGC-Tsc12/2 ovaries de-
generated by 4 months of age (Figure S2F, inset, arrowheads),
which is in sharp contrast to the normal follicular development
in pfGC-Tsc1+/+ ovaries at 4 months (Figure S2E).
These results showed that elevated mTORC1 signaling in
the pfGCs caused premature differentiation and proliferation
of pfGCs into granulosa cells and the awakening of all dormant
oocytes in primordial follicles.
Our previous studies have shown that intraoocyte PI3K
signaling plays a key role in controlling the growth of oocytes
during the activation of primordial follicles in mice [16]. There-
fore, we tested whether the overactivation of dormant oocytes
in pfGC-Tsc12/2 ovaries was caused by a pfGC-initiated
elevation of intraoocyte PI3K signaling. We performed immu-
nofluorescence staining of FOXO3 (forkhead box O3), a
downstream effector of PI3K-Akt, in the ovaries of pfGC-
Tsc12/2 mice. FOXO3 shuttles from the nucleus to the cyto-
plasm of mouse oocytes when PI3K signaling is activated inthe oocytes [17]. We observed a clear cytoplasmic localization
of FOXO3 in pfGC-Tsc12/2 oocytes (Figure 2J), indicating
constitutively active PI3K signaling in the oocytes of pfGC-
Tsc12/2 ovaries. This is in sharp contrast to the nuclear
localization of FOXO3 in the oocytes of primordial follicles in
pfGC-Tsc1+/+ females (Figure 2I). Therefore, our results show
that the pfGC-initiated awakening of dormant oocytes in
pfGC-Tsc12/2 ovaries occurs via activation of the oocyte
PI3K pathway, which is in agreement with previous reports
that the activation of intraoocyte PI3K signaling is needed for
the activation of primordial follicles [16, 18].
mTORC1 Signaling in PfGCs Triggers Oocyte Awakening
through the Interaction between KITL from PfGCs and KIT
Signaling in Oocytes
To investigate the underlyingmechanisms governing the inter-
actions between somatic pfGCs and dormant oocytes, we first
used an in vitro organ-culture method to analyze how pfGCs
stimulate the accelerated awakening of dormant oocytes in
pfGC-Tsc12/2 ovaries. The ovaries from PD10 pfGC-Tsc12/2
mice were harvested and cultured in vitro for 4 days. Over
the 4-day in vitro culture period, in comparison to the normal
primordial follicle distribution in pfGC-Tsc1+/+ ovaries (Fig-
ure S3A), pfGC-Tsc12/2 ovaries also showed premature awak-
ening of dormant oocytes (Figure 3A, arrows; Figure S3B). We
then cultured PD10 pfGC-Tsc12/2 ovaries for 4 days with in-
hibitors of different signaling pathways that are important for
the awakening of oocytes, including rapamycin (an mTORC1
inhibitor), LY294002 (a PI3K inhibitor), genistein (a general pro-
tein tyrosine kinase inhibitor), and several inhibitors of recep-
tor protein tyrosine kinases, including ISCK03 (a KIT inhibitor),
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tor), and AGL 2263 (an insulin receptor and insulin-like growth
factor [IGF] receptor inhibitor) [19].
As expected, we found that the mTORC1 inhibitor rapamy-
cin (10 mM) (Figure 3B, arrowheads), the PI3K inhibitor
LY294002 (10 mM) (Figure S3C, arrowheads), and the general
protein tyrosine kinase inhibitor genistein (50 mM) (Figure S3D,
arrowheads) suppressed the premature awakening of dormant
oocytes in cultured pfGC-Tsc12/2 ovaries. Notably, the KIT in-
hibitor ISCK03 (5 mM) suppressed oocyte awakening in
cultured pfGC-Tsc12/2 ovaries (Figure 3C, arrowheads), but
inhibitors for other receptor protein tyrosine kinases did not
suppress the premature awakening of dormant oocytes in
pfGC-Tsc12/2 ovaries (Figures S3E–S3G). These results sug-
gest that the signaling between KITL in pfGCs and KIT
signaling in oocytes mediates the premature awakening of
dormant oocytes in pfGC-Tsc12/2 ovaries.
Indeed, we found that at PD13 (a stage at which no apparent
premature awakening of dormant oocytes had yet occurred in
pfGC-Tsc12/2 ovaries but the pfGC differentiation into granu-
losa cells had started) (Figures S2A and S2B), the Kitl mRNA
level in pfGC-Tsc12/2 ovaries was 2.3-fold higher than that in
pfGC-Tsc1+/+ ovaries (Figure 3D). This result indicates that
active mTORC1 signaling enhances the expression of KITL in
pfGCs.
PfGCsAwakenDormant Oocytes through Phosphorylation
of KIT Y719 and Subsequent Activation of PI3K Signaling in
the Oocytes
To further determine how the KITL-KIT signaling and the intra-
oocyte PI3K pathway function to awaken dormant oocytes in
pfGC-Tsc12/2 ovaries, we blocked the KIT-mediated activa-
tion of oocyte PI3K in pfGC-Tsc12/2 mice by crossing pfGC-
Tsc12/2 mice with KitY719F/KitY719F mice that carry a point
mutation in which KIT Y719 is substituted by a phenylalanine
(F) [20]. The phosphorylation of KIT Y719 upon KITL binding
is responsible for activating the downstream PI3K [20], and
the Y719F mutation in the pfGC-Tsc12/2;KitY719F/KitY719F
mice should prevent the KIT-mediated activation of PI3K in
their oocytes.
We first validated the inhibition of PI3K activation in the
oocytes of KitY719F/KitY719F mice. FOXO3, a downstream
effector of PI3K-Akt, was localized in the nuclei of oocytes
(Figure S4A, upper inset, arrows), and this demonstrated
suppressed PI3K signaling [17] in the oocytes of the
KitY719F/KitY719F mice. Not surprisingly, the development of
oocytes and follicles was greatly retarded in KitY719F/
KitY719F ovaries (Figure S4). However, compared to the
pfGCs in pfGC-Rptor2/2 ovaries (Figures 1G and 1I)—which
are arrested in an undifferentiated stage with flattened
shapes—the pfGCs in KitY719F/KitY719F ovaries can differen-
tiate into cuboidal granulosa cells (Figure S4C, inset, arrows).
This shows that there is no defect in the differentiation of
pfGCs in KitY719F/KitY719F mice.
After tamoxifen administration at PD1 and PD4, we found no
apparent morphological difference between the ovaries of
pfGC-Tsc12/2;KitY719F/KitY719F mice (Figure 4A) and those of
pfGC-Tsc12/2 mice (Figure 4B) at PD4. At PD23, however,
the ovaries from pfGC-Tsc12/2;KitY719F/KitY719F mice (Fig-
ure 4C) were much smaller than those of pfGC-Tsc12/2 mice
(Figure 4D). This was due to the large numbers of dormant
oocytes in the double mutant pfGC-Tsc12/2;KitY719F/KitY719F
ovaries (Figure 4E, arrows). It was apparent that the premature
awakening of dormant oocytes seen in PD23 pfGC-Tsc12/2mice (Figures 4D and 4F, arrows) was effectively blocked in
the pfGC-Tsc12/2;KitY719F/KitY719F mice (Figures 4C and 4E).
It is worth noting that the differentiation and proliferation of
pfGCs into granulosa cells occurred normally in the ovaries of
pfGC-Tsc12/2;KitY719F/KitY719F mice (Figure 4E, arrowheads).
However, the inability to activate PI3K signaling in oocytes
due to the KIT Y719Fmutation prevented the dormant oocytes
from being awakened (Figure 4E, arrows). Indeed, in PD23
pfGC-Tsc12/2;KitY719F/KitY719F ovaries, the average diameter
of the oocytes in activated follicles was 16.4 6 1.2 mm. This
was in sharp contrast to the enlarged oocytes in the prema-
turely activated follicles (53.2 6 5.1 mm) in PD23 ovaries of
pfGC-Tsc12/2 mice (Figure 4F, arrows; Figure 4G). Moreover,
a comparable level of Kitl mRNA expression was found in
pfGC-Tsc12/2 ovaries and pfGC-Tsc12/2;KitY719F/KitY719F
ovaries (Figure 4H), and this indicates that the expression of
Kitl in pfGCs is directly controlled by the mTORC1 signaling
in pfGCs and not by indirect regulation through the activation
of primordial follicles.
To confirm that the suppressed oocyte awakening in pfGC-
Tsc12/2;KitY719F/KitY719F ovaries was indeed caused by the
inability to activate oocyte PI3K signaling, we studied
FOXO3 localization as an indicator of PI3K activation. There
was a clear cytoplasmic localization of FOXO3 in most pfGC-
Tsc12/2 oocytes at PD23 (Figure 4J), indicating activated
PI3K signaling in the oocytes of pfGC-Tsc12/2 ovaries. In
contrast, in pfGC-Tsc12/2;KitYY719F/KitY719F ovaries, FOXO3
was mainly detected in the nuclei of the oocytes (Figure 4I),
indicating suppressed PI3K signaling. Therefore, the sup-
pressed oocyte awakening in pfGC-Tsc12/2;KitYY719F/
KitY719F ovaries was caused by the failure to activate PI3K
signaling in the oocytes.
The above results showed that the KIT Y719-mediated PI3K
activation is the sole mechanism responsible for the initiation
of oocyte awakening in pfGC-Tsc12/2 ovaries. Even though
the differentiation and proliferation of pfGCs into cuboidal
granulosa cells occurred normally in pfGC-Tsc12/2;KitY719F/
KitY719F ovaries (Figure 4E, arrowheads), the KIT Y719F muta-
tion prevented activation of PI3K signaling in oocytes and the
dormant oocytes could not be awakened (Figure 4E, arrows).
Based on these results, we conclude thatmTORC1 signaling
in pfGCs plays an indispensable role in initiating the activation
of primordial follicles and the awakening of dormant oocytes.
As summarized in Figure 5, this is achieved first through
mTORC1 activation in pfGCs that mediates the differentiation
and proliferation of pfGCs into granulosa cells as well as the
expression of KITL. Binding of KITL to KIT results in the phos-
phorylation of KIT Y719 and subsequent activation of oocyte
PI3K signaling. The PI3K signaling in the oocytes is then
responsible for triggering the events that awaken the oocyte
from its quiescent state, as proposed earlier [16, 18]. We pro-
pose that this specific gateway through phosphorylation of KIT
Y719 makes for an easily regulated system for limiting the
number of primordial follicles that are activated at any given
time in the mouse ovary.
Discussion
In this study, we have shown that pfGCs—the somatic compo-
nents of the primordial follicle—play a fundamental role in initi-
ating the activation of primordial follicles and governing the
quiescent or awakening states of dormant oocytes in the
mammalian ovary. We have described a complete set of
molecular networks that mediate the interaction between
Figure 4. KIT Y719-PI3K Signaling in Oocytes Is Responsible for the Awak-
ening of Dormant Oocytes upon Activation by KITL from PfGCs
Tamoxifen was administered to pups at PD1 and PD4 (20 mg$kg21 body
weight) and the ovaries were collected at PD4 and PD23.
(A and B) The ovarian morphologies are comparable in pfGC-Tsc12/2;
KitY719F/KitY719F and pfGC-Tsc12/2 mice at PD4.
(C–F)AtPD23, thedevelopmentofoocyteswasarrested in thepfGC-Tsc12/2;
KitY719F/KitY719F double mutant mouse ovaries (C and E, arrows), and few
enlarged oocytes were found in the ovaries (C). This is in sharp contrast to
the premature awakening of all dormant oocytes in the pfGC-Tsc12/2 ovary
(D and F, arrows). The follicles in the pfGC-Tsc12/2;KitY719F/KitY719F ovary
consist of mostly dormant oocytes (E, arrows), but these follicles have single
or multiple layers of cuboidal granulosa cells (E, arrowheads).
Figure 5. The Proposed Signaling Cascade frommTORC1-KITL in PfGCs to
KIT Y719-PI3K in Oocytes that Is Responsible for Regulating the Quies-
cence or Awakening of Dormant Oocytes in Primordial Follicles
Left: if the mTORC1 signaling in pfGCs is suppressed, no or low levels of
KITL are expressed by pfGCs, and this is insufficient to activate KIT on
oocytes. In this situation, KIT Y719 is not phosphorylated and the intraoo-
cyte PI3K signaling is suppressed, and this maintains the dormant oocytes
in their quiescent state. Right: in a primordial follicle that is selected for acti-
vation, elevated mTORC1 signaling in the pfGCs leads to enhanced produc-
tion of KITL that binds to KIT and subsequently activates the intraoocyte
PI3K signaling through phosphorylation of KIT Y719. Activated PI3K
signaling in oocytes awakens the dormant oocytes. Y719-P, phosphory-
lated KIT Y719.
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2506somatic cells and germ cells in controlling the development of
dormant mammalian oocytes (Figure 5). Themodel we present
in this work has two key steps. The first is the initial up- and
downregulation of mTORC1 signaling in pfGCs that acts as
the key decision-making process with regard to whether or
not a primordial follicle will be activated. The second step(G) The average diameter of the oocytes in the activated follicles of pfGC-
Tsc12/2;KitY719F/KitY719F ovaries is significantly smaller than that of pfGC-
Tsc12/2 ovaries (16.4 6 1.2 mm versus 53.2 6 5.1 mm, respectively). For
each experiment, 100 oocytes in each group from three mice were
measured and data are represented as means 6 SEM.
(H) At PD13, the expression of Kitl mRNA was increased in both pfGC-
Tsc12/2 and pfGC-Tsc12/2;KitY719F/KitY719F ovaries, and comparable
levels of Kitl mRNA were observed in pfGC-Tsc12/2 and pfGC-Tsc12/2;
KitY719F/KitY719F ovaries. The mRNA levels in pfGC-Tsc1+/+ ovaries were
defined as 1.0. The mRNA level of Gapdh was used as the internal control.
For each experiment, materials from four mice were used and data are rep-
resented as means 6 SEM.
(I and J) Nuclear localization of FOXO3 (green fluorescence) was observed in
the oocytes of PD23 pfGC-Tsc12/2;KitY719F/KitY719F ovaries, indicating sup-
pressed PI3K signaling in the oocytes (I). FOXO3 was localized in the cyto-
plasm of oocytes from pfGC-Tsc12/2 ovaries, showing active PI3K signaling
in these oocytes (J). The experiments were repeated at least three times,
and representative images are shown.
See also Figure S4.
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2507involves the tightly regulated communication channel from the
somatic cells to the germ cells via KITL-KIT Y719 to trigger the
awakening of the oocyte. We propose that these processes
ensure the progressive activation of a limited number of pri-
mordial follicles throughout the reproductive lifespan. Thus,
it is likely that follicular activation is initiated by molecular
and cellular changes in the somatic pfGCs that are followed
by awakening of the dormant oocytes.
We and others have previously shown that activated PI3K
signaling in oocytes is essential for follicular activation in
mouse ovaries [16, 18]. In the present study, we have
expanded upon this and shown that the PI3K signaling in
dormant mouse oocytes is downstream of the mTORC1-
KITL cascade in pfGCs and the KIT Y719 signaling in oocytes.
Thus, we can now draw a relatively complete picture of how
the entire follicular activation process is initiated and of the
molecular cascades involved in this process.
Our previous studies have shown that overactivation of
mTORC1 signaling in the oocytes of primordial follicles
leads to a global activation of the follicular pool [21, 22]. How-
ever, our unpublished data showed that the inhibition of
mTORC1 signaling in oocytes by deletion of Rptor has no
effect on follicular development and female fertility, and this
shows that mTORC1 signaling in dormant oocytes is not
essential for physiological follicular activation. Therefore,
the mTORC1 signaling appears to only be essential in the
pfGCs for controlling the activation of primordial follicles
under physiological conditions, and more studies are needed
to determine the downstream events through which mTOR
signaling regulates KITL production in pfGCs and granulosa
cells.
In mammals, only a limited number of primordial follicles
are selectively activated, and most of the dormant follicles
remain arrested in a quiescent state. This allows for an
extended female reproductive lifespan. The upstream regula-
tors of mTORC1 signaling include nutrition, oxygen, energy,
and growth factors [10]. Our current study reveals that the
mTORC1 signaling in pfGCs, which is potentially directly regu-
lated by the local microenvironment, including factors trans-
ported by surrounding blood vessels, plays a primary role in
controlling the developmental fates of single primordial folli-
cles. Therefore, we hypothesize that the individual microenvi-
ronment and microcirculation surrounding each primordial
follicle decide the activation of selected primordial follicles at
any given time during the female’s reproductive life.
In recent years, there has been an increasing trend to use
in vitro activation and maturation of dormant oocytes in pri-
mordial follicles to obtain fertilizable human oocytes [23]. A
healthy baby has recently been born from a primordial follicle
of a woman with premature ovarian failure that was activated
in vitro by enhancing PI3K signaling with PTEN (phosphatase
and tensin homolog deleted on chromosome 10) inhibitors
[24]. We thus propose that to achieve optimal activation of hu-
man primordial follicles during in vitro culture, it is necessary to
first treat them with an mTORC1 activator to trigger the differ-
entiation and proliferation of the pfGCs and the awakening of
the oocytes. This can be followed by treatment with PTEN in-
hibitors to enhance the growth of the oocytes.
In summary, we have presented a complete network in
the pfGCs that initiates the activation of primordial follicles
and controls the development of dormant oocytes in the
mammalian ovary. The results presented here will open new
avenues to a better understanding of ovarian physiology and
pathology.Experimental Procedures
Mice
RptorloxP/loxP mice (013188), Tsc1loxP/loxP mice (005680), and mTmG mice
(007576) were purchased from the Jackson Laboratory. The KitY719F mice
were kindly provided by Peter Besmer of the Memorial Sloan Kettering
Cancer Center. After backcrossing to a C57BL/6J genomic background,
the mice were crossed with knockin mice carrying a CreERT2 transgene
mediated by the Foxl2 promoter (Foxl2-CreERT2 mice), which were also in
a C57BL/6J genomic background, as we reported earlier [12]. After multiple
rounds of crossing, we obtained homozygous RptorloxP/loxP;Foxl2-CreERT2
mice (designated pfGC-Rptor2/2 mice), Tsc1loxP/loxP;Foxl2-CreERT2 mice
(designated pfGC-Tsc12/2 mice), Tsc1loxP/loxP;Foxl2-CreERT2;KitY719F/
KitY719F mice (designated pfGC-Tsc12/2;KitY719F/KitY719F mice), and Foxl2-
CreERT2;mTmG mice.
Upon tamoxifen injection in these mouse models, the CreERT2 recombi-
nase enters the nucleus and mediates recombination at the loxP locus, re-
sulting in a deletion of the target gene in Foxl2-positive pfGCs and granulosa
cells. Littermates that do not carry CreERT2 were used as control mice and
are referred to as pfGC-Rptor+/+ or pfGC-Tsc1+/+ mice. For KitY719F/KitY719F
mice, littermates that do not carry the mutation were used as control mice.
The mice were housed under controlled environmental conditions with
free access to water and food. Illumination was on between 0600 and
1800. Experimental protocols were approved by the regional ethical com-
mittee of the University of Gothenburg.
Reagents and Immunological Detection Methods
Tamoxifen and corn oil were purchased from Sigma-Aldrich. The rabbit
polyclonal antibodies to phospho-EIF4EBP1 (S65) and phospho-RPS6KB1
(T389) and rabbit monoclonal antibodies to EIF4EBP1, RPS6KB1, and
FOXO3were obtained fromCell Signaling Technologies.Mousemonoclonal
antibodies to b-actin, polyethylene glycol 400, and Tween 80 were pur-
chased from Sigma-Aldrich. The western blots were carried out according
to the instructions of the suppliers of the different antibodies and visualized
using the ECL Plus Western Blotting Detection System (Amersham Biosci-
ences). Paraffin and hematoxylin were purchased from Histolab.
The PI3K inhibitor LY294002, the mTORC1 inhibitor rapamycin, and the
general protein tyrosine kinase inhibitor genistein were obtained from LC
Laboratories. The KIT inhibitor ISCK03 was obtained from Sigma-Aldrich.
The insulin receptor and IGF receptor inhibitor AGL 2263 and the platelet-
derived growth factor receptor inhibitor GTP-14564 were purchased from
Calbiochem.
Tamoxifen Administration for Specifically Targeting PfGCs in
Foxl2-CreERT2 Mice
Tamoxifen was resuspended at 100 mg$ml21 in 95% ethanol and further
diluted with corn oil to a final concentration of 20 mg$ml21. To specifically
target the pfGCs in primordial follicles, tamoxifen was given to neonatal
female pups at PD1 and PD4 (20 mg$kg21 body weight) by intraperitoneal
injection. Based on previous reports, the recruitment of Foxl2-positive
pfGCs is finished around PD5 and the primordial follicle pool is established
at the same time [12]. This makes our approach ideal for deleting genes in
the pfGCs of primordial follicles.
Histological Analysis and Immunofluorescence Staining
To observe the ovarianmorphology, ovaries were fixed in 4%paraformalde-
hyde, dehydrated, and embedded in paraffin. The paraffin-embedded
ovaries were serially cut into 8 mm sections and rehydrated. For morpholog-
ical analysis, the sections were stained with hematoxylin and imaged with a
Zeiss Axio Scope A1 upright microscope. The fluorescent images of Foxl2-
CreERT2;mTmG ovarian sections were taken with the Zeiss Axio Scope A1
upright microscope installed with filter sets for mT (tdTomato, 554/
581 nm) and mG (EGFP, 488/507 nm) and merged with Zeiss AxioVision
software.
To detect the activation of PI3K signaling in oocytes by FOXO3 immuno-
fluorescence staining, the sections were treated with 0.01% sodium citrate
buffer (pH 6.0) for antigen retrieval. After blocking by 1.5% goat serum in
PBS, the sections were incubated with FOXO3 primary antibodies overnight
at 4C and Alexa Fluor 488-conjugated secondary antibodies (Cell
Signaling) at 37C for 1 hr. The sections were then stained with 40,6-diami-
dino-2-phenylindole (DAPI) (Sigma-Aldrich) for 5 min. The fluorescent
images were taken with a Zeiss Axio Scope A1 upright microscope.
For oocyte diameter measurement, the ovaries were serially cut into 8 mm
sections and rehydrated and the sections were stained with hematoxylin
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2508and imaged with a Zeiss Axio Scope A1 upright microscope. The diameters
of the oocytes were measured with Zeiss AxioVision software. In each
group, the average diameter was calculated from measurements of 100
random oocytes in the sections.
For quantification of ovarian follicles, ovaries were fixed in 4% parafor-
maldehyde, dehydrated, and embedded in paraffin. Paraffin-embedded
ovaries were serially cut into 8 mm sections and stained with hematoxylin
for morphological observation. The numbers of primordial follicles and acti-
vated follicles were counted in all sections of an ovary.
In Vitro Culture of Mouse Ovaries
Paired ovaries from PD10 pfGC-Tsc12/2 female mice were collected and
washed three times in DMEM/Ham’s F12 medium (Invitrogen). Ovaries
were cultured on Millicell inserts (Millipore) in 24-well plates (Nunc) with
500 ml of culture medium. The culture medium consisted of DMEM/Ham’s
F12 supplemented with 3 mg$ml21 BSA (Sigma), 13 Insulin-Transferrin-
Selenium (Invitrogen), 50 U$ml21 penicillin (Invitrogen), 50 mg$ml21 strepto-
mycin (Invitrogen), and 2 mM L-glutamine (Invitrogen). Ovaries were
cultured for 4 days with or without the inhibitors at 37C in a humidified
atmosphere of 5% CO2.
Gene Expression Analysis
For the gene expression measurements in the mouse materials, total RNA
was isolated from ovaries of eight mice per group with the RNeasy Mini
Kit (QIAGEN) according to the manufacturer’s instructions. First-strand
cDNA was synthesized with the iScript cDNA Synthesis Kit (QIAGEN). Syn-
thesized cDNA was subjected to real-time PCR for measuring Kitl with the
primer pairs 50-TCAACTATGTCGCCGGGATG-30 and 50-CGAAATGAGAG
CCGGCAATG-30 on an ABI 7500 Real-Time PCR System using SYBR Green
PCR Master Mix (Applied Biosystems). The reactions were carried out in
triplicate. Threshold cycle (Ct) values were obtained, and the DDCt method
was used to calculate the fold changes. All of the values were normalized to
levels of Gapdh.
Statistical Analysis
All experiments were repeated at least three times. Quantitative data
(means 6 SEM) were analyzed by one-way ANOVA using SigmaPlot soft-
ware (Systat Software).
Supplemental Information
Supplemental Information includes four figures and can be found with this
article online at http://dx.doi.org/10.1016/j.cub.2014.09.023.
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